About half of the claims were related to COVID vaccine, but the vast majority of money paid for claims—$6.5 million—was for harms tied to the H1N1 flu vaccine.
Review of US vaccine injury reimbursement program shows less than 3% of claims eligible for compensation
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- US flu season shows signs of peak
- Hospitalized COVID patients at higher risk for organ-related death, readmission for 2.5 years, data suggest
- Liberals’, conservatives’ trust in US government’s use of digital health data diverged during COVID
- Report: COVID survivors nearly twice as likely to have ongoing symptoms as those with flu